24 results
8-K
EX-99.1
OVID
Ovid Therapeutics Inc
8 Mar 24
Ovid Therapeutics Reports Business Updates, Fourth Quarter and Full Year 2023 Financial Results
8:20am
for its current pipeline programs and clinical results for soticlestat from Takeda in 2024.
◦To manage its capital resources, the Company leadership has
8-K
EX-99.1
OVID
Ovid Therapeutics Inc
4 Aug 23
Ovid Therapeutics Reports Second Quarter 2023 Financial Results and Corporate Updates
9:10am
with Graviton Bioscience to develop highly selective ROCK2 inhibitors for rare neurological conditions
Expanded scientific leadership team … -related disorders and other brain diseases. Our experienced team, under the leadership of Drs. Zhong Zhong and Manoj Malhotra, as our respective
8-K
EX-99.1
OVID
Ovid Therapeutics Inc
5 May 23
Ovid Therapeutics Reports First Quarter 2023 Financial Results and Corporate Updates
8:16am
and leadership team to steward the business and its programs.
Pipeline Update
GV101 and selective ROCK2 inhibitor library: In May 2023, Ovid entered
8-K
EX-99.1
ilp s8c6d
16 Aug 21
Ovid Therapeutics Reports Second Quarter 2021 Financial Results
8:06am
8-K
EX-99.1
qms21no
23 Jun 21
Regulation FD Disclosure
8:05am
8-K
EX-99.1
g48umcf6xem8uw1
18 May 21
Regulation FD Disclosure
3:11pm
8-K
EX-99.1
hcw8x4xxkguf 2f9
13 May 21
Ovid Therapeutics Reports First Quarter 2021 Financial Results and Provides Corporate Update
4:44pm
8-K
EX-99.1
gixvx x37y6
19 Apr 21
Regulation FD Disclosure
4:22pm
8-K
EX-99.1
n87ora03f33z t5o
9 Apr 21
Regulation FD Disclosure
10:01am
8-K
EX-99.1
f97 6j7dibxhlmzy7i
13 Mar 20
Regulation FD Disclosure
9:06am
8-K
EX-99.1
ds77a2wkw0ob
11 Mar 20
Ovid Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results, Provides Corporate Update for 2020
8:05am
8-K
EX-99.1
e0fig9qu7cpt
2 Mar 20
Regulation FD Disclosure
3:48pm
8-K
EX-99.1
bd1ujx
7 Jan 20
Ovid Therapeutics Provides 2020 Update in Preparation for Multiple Clinical Data Readouts Across Rare Neurological Disease Platform
8:05am
8-K
EX-99.1
924ips08d qnd
1 Nov 19
Ovid Therapeutics Announces Senior Management Promotions in Preparation for Multiple Data Readouts Expected in 2020
8:23am